Amgen’s stock may see worst day in 24 years as weight-loss-drug data underwhelms

• Amgen says no concerns around weight loss drug’s bone density data after stock falls

  Business - CNBC - November 13
• 

  New Obesity Drug MariTide Helps Patients Lose Up to 20% of Weight, Early Data Shows

  Business - The New York Times - 14 hours ago

• Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau

  Business - CNBC - 12 hours ago

• AstraZeneca sheds £15 billion of market cap as weight-loss-pill data underwhelms investors

  Business - MarketWatch - November 5

• Microsoft's stock has worst day in two years after disappointing forecast

  Business - CNBC - October 31

More from MarketWatch

• EasyJet ups dividend on surging profits from ‘record breaking’ summer

  Business - MarketWatch - 11 minutes ago

• Here’s how much prices of Modelo and Corona beer will have to rise to cover tariffs

  Business - MarketWatch - 23 minutes ago

• Treasury yields fall as traders await PCE inflation data

  Business - MarketWatch - 30 minutes ago

• Biden’s plan for Medicare coverage of weight-loss drugs would drive up costs by billions of dollars

  Business - MarketWatch - 6 hours ago

• Dell’s AI boost derailed slightly by Blackwell transition and slower move to AI PCs

  Business - MarketWatch - 7 hours ago